Vaxcyte, Inc.
US ˙ NasdaqGS ˙ US92243G1085

SecurityPCVX / Vaxcyte, Inc.
InstitutionTrexquant Investment LP
Latest Disclosed Ownership49,212 shares
Latest Disclosed Value $ 2,859,709
Trexquant Investment LP ownership in PCVX / Vaxcyte, Inc.

On May 15, 2026 - Trexquant Investment LP filed a 13F-HR form disclosing ownership of 49,212 shares of Vaxcyte, Inc. (US:PCVX) valued at $2,859,709 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 0 shares of Vaxcyte, Inc.. The current value of the position is $2,309,519 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VAXCYTE COM 92243G108 49,212 49,212 2,860 0.0205
2026-02-17 2025-12-31 13F VAXCYTE COM 92243G108 0 -119,850 -100.00 0 -100.00
2025-11-14 2025-09-30 13F VAXCYTE COM 92243G108 119,850 13,569 12.77 4,317 24.92 0.0444
2025-08-12 2025-06-30 13F VAXCYTE COM 92243G108 106,281 106,281 3,455 0.0390
2025-05-14 2025-03-31 13F VAXCYTE COM 92243G108 0 -66,249 -100.00 0 -100.00
2025-02-12 2024-12-31 13F VAXCYTE COM 92243G108 66,249 -13,689 -17.12 5,423 -40.63 0.0632
2024-11-12 2024-09-30 13F VAXCYTE COM 92243G108 79,938 79,938 9,135 0.1156
2024-02-09 2023-12-31 13F VAXCYTE COM 92243G108 0 -43,329 -100.00 0 -100.00
2023-11-13 2023-09-30 13F VAXCYTE COM 92243G108 43,329 38,058 722.03 2,209 739.54 0.0554
2023-08-11 2023-06-30 13F VAXCYTE COM 92243G108 5,271 -33,893 -86.54 263 -82.07 0.0069
2023-05-15 2023-03-31 13F VAXCYTE COM 92243G108 39,164 22,559 135.86 1,468 84.30 0.0403
2023-02-13 2022-12-31 13F VAXCYTE COM 92243G108 16,605 16,605 796 0.0226
2022-11-14 2022-09-30 13F VAXCYTE COM 92243G108 0 -16,851 -100.00 0 -100.00
2022-08-11 2022-06-30 13F VAXCYTE COM 92243G108 16,851 16,851 367 0.0164
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.